达芬奇机器人经口切除喉及下咽肿瘤的初步经验

孟令照; 房居高; 王建宏; 袁先道; 杨帆; 饶远生; 冯燕军; 魏永祥

doi:10.13201/j.issn.1001-1781.2018.14.006

达芬奇机器人经口切除喉及下咽肿瘤的初步经验

- 1. 首都医科大学附属北京安贞医院耳鼻咽喉头颈外科(北京, 100029);
- 2. 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科
基金项目:
首都医科大学耳鼻咽喉头颈外科学教育部重点实验室开放课题（No：2017EBYH03）

详细信息

通讯作者: 房居高,E-mail:fangjugao@163.com; 魏永祥,E-mail:weiyongxianganzhen@163.com

中图分类号: R739.6

收稿日期: 2018-05-29

Preliminary experience of transoral robotic surgery in laryngeal and hypopharyngeal tumors with da Vinci surgical system

- 1. Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China;
- 2. Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University

More Information

Corresponding authors: FANG Jugao ; WEI Yongxiang

Received Date: 29 May 2018

摘要

摘要: 目的：总结达芬奇机器人手术系统经口切除喉及下咽部肿瘤的临床经验。方法：回顾分析2016-07-01-2018-01-31期间首都医科大学附属北京安贞医院耳鼻咽喉头颈外科共12例达芬奇机器人经口切除喉及下咽部肿瘤患者的临床资料。其中喉肿瘤7例，下咽肿瘤5例。结果：男10例，女2例。年龄30~81岁（中位年龄58岁）。12例均用达芬奇机器人经口入路完全切除，无中转开放病例。机器人平均手术时间为31.7 min，平均出血量为12.3 ml，平均经口进食时间为4.6 d。术后切缘均为阴性，同期行颈部淋巴结清扫8例，术后辅助放疗7例。术中术后无严重并发症出现。术后随访3~20个月，1例颈部淋巴结转移，无局部复发、远处转移或死亡病例。结论：在经选择的病例中，达芬奇机器人经口切除喉及下咽肿瘤是一种安全可行的微创外科方法。
- 经口机器人手术 /
- 喉 /
- 下咽 /
- 肿瘤 /
- 微创外科
Abstract: Objective: The purpose of this study was to summarize preliminary clinical experience of transoral robotic surgery (TORS) in laryngeal and hypopharyngeal tumors with da Vinci surgical system.Method: Twelve patients were reviewed who were diagnosed with laryngeal (n=7) and hypopharyngeal tumors (n=5) and treated with TORS in Beijing Anzhen Hospital from July 1, 2016 to January 31, 2018.Result: Ten cases were male and two cases were female. The median age was 58 years old (ranging from 30 to 81 years). The robotic surgeries were performed successfully on all of the 12 patients. The average surgical time was 31.7 min. The average blood loss was 12.3 ml. The average recovery time for oral intake was 4.6 day. All surgical resection margins were free of carcinoma. Eight cases received neck dissection and 7 cases received adjuvant radiotherapy. There were no perioperative complications. There was no local recurrence, metastasis or death except 1 regional recurrence with a follow-up of 3 to 20 months.Conclusion: TORS is a feasible, safe, minimally invasive, and effective surgical procedure in selected laryngeal and hypopharyngeal tumors.
- transoral robotic surgery /
- larynx /
- hypopharynx /
- tumors /
- minimally invasive surgery

HTML全文

参考文献(16)

[1]	MCLEOD I K, MELDER P C.Da Vinci robot-assisted excision of a vallecular cyst:a case report[J].Ear Nose Throat J, 2005, 84:170-172.
[2]	HAMILTON D, PALERI V.Role of transoral robotic surgery in current head&neck practice[J].Surgeon, 2017, 15:147-154.
[3]	BEKENY J R, OZER E.Transoral robotic surgery frontiers[J].World J Otorhinolaryngol Head Neck Surg, 2016, 2:130-135.
[4]	FRIEDMAN M, IBRAHIM H, BASS L.Clinical staging for sleep-disordered breathing[J].Otolaryngol Head Neck Surg, 2002, 127:13-21.
[5]	PAUL R R, VARGHESE A M, MATHEW J, et al.Difficult laryngeal exposure in microlaryngoscopy:Can it be predicted preoperatively[J]?Indian J Otolaryngol Head Neck Surg, 2016, 68:65-70.
[6]	PIAZZA C, MANGILI S, BON F D, et al.Preoperative clinical predictors of difficult laryngeal exposure for microlaryngoscopy:the Laryngoscore[J].Laryngoscope, 2014, 124:2561-2567.
[7]	DE VIRGILIO A, PARK Y M, KIM W S, et al.How to optimize laryngeal and hypopharyngeal exposure in transoral robotic surgery[J].Auris Nasus Larynx, 2013, 40:312-319.
[8]	MOORE E J, VAN ABEL K M, OLSEN K D.Transoral robotic surgery in the seated position:Rethinking our operative approach[J].Laryngoscope, 2017, 127:122-126.
[9]	MENDELSOHN A H, REMACLE M, VAN DERVORST S, et al.Outcomes following transoral robotic surgery:supraglottic laryngectomy[J].Laryngoscope, 2013, 123:208-214.
[10]	KAYHAN F T, KAYA K H, ALTINTAS A, et al.Transoral robotic supraglottic partial laryngectomy[J].J Craniofac Surg, 2014, 25:1422-1426.
[11]	OZER E, ALVAREZ B, KAKARALA K, et al.Clinical outcomes of transoral robotic supraglottic laryngectomy[J].Head Neck, 2013, 35:1158-1161.
[12]	RAZAFINDRANALY V, LALLEMANT B, AUBRYK, et al.Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma:Experience of a French evaluation cooperative subgroup of GETTEC[J].Head Neck, 2016, 38Suppl 1:E1097-E1101.
[13]	PARK Y M, KIM W S, BYEON H K, et al.Feasiblity of transoral robotic hypopharyngectomy for earlystage hypopharyngeal carcinoma[J].Oral Oncol, 2010, 46:597-602.
[14]	LORINCZ B B, BUSCH C J, MOCKELMANN N, et al.Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer:a subset analysis of the Hamburg University TORS-trial[J].Eur Arch Otorhinolaryngol, 2015, 272:2993-2998.
[15]	WANG C C, LIU S A, WU S H, et al.Transoral robotic surgery for early T classification hypopharyngeal cancer[J].Head Neck, 2016, 38:857-862.
[16]	PARK Y M, JUNG C M, CHA D, et al.The long-term oncological and functional outcomes of transoral robotic surgery in patients with hypopharyngeal cancer[J].Oral Oncology, 2017, 71:138-143.